Ovid Therapeutics
OVID
OVID
67 hedge funds and large institutions have $109M invested in Ovid Therapeutics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-5
Holders Change %
-6.94%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
15
Reduced
22
Closed
16
Calls
$1.2M
Puts
–
Net Calls
+$1.2M
Net Calls Change
+$2.11M
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.42M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$983K |
| 3 |
CA
CHI Advisors
New York
|
+$534K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$439K |
| 5 |
Bank of New York Mellon
New York
|
+$433K |
